Pelvic Floor Dysfunction is a series of chronic diseases caused by the damage or dysfunction of the pelvic floor muscles, ligaments, and fascia, with a global incidence of over 30% in adult women, and up to 40%–50% in postmenopausal women and multiparous women.

Core types include stress urinary incontinence (SUI), pelvic organ prolapse (POP, including uterine prolapse, cystocele, rectocele, and vaginal vault prolapse), female sexual dysfunction, and chronic pelvic pain. The main causes include pregnancy and vaginal delivery, aging, menopause, obesity, long-term increased abdominal pressure, and pelvic surgery history. The disease does not threaten life, but seriously affects women's quality of life, social activities, and mental health, and is known as the "social cancer".

• Conservative Treatment: The first-line treatment for mild to moderate PFD, including pelvic floor muscle training (Kegel exercise), biofeedback therapy, electrical stimulation, pelvic floor rehabilitation, lifestyle intervention (weight loss, smoking cessation), and drug therapy (estrogen replacement therapy for postmenopausal women).
• Surgical Treatment: For moderate to severe PFD with obvious symptoms, the mainstream is minimally invasive surgery, including tension-free vaginal tape (TVT/TVT-O) for stress urinary incontinence, laparoscopic sacrocolpopexy/sacrouteropexy for pelvic organ prolapse, vaginal mesh repair, and native tissue repair. Robot-assisted minimally invasive surgery is available for complex cases, with higher accuracy and less trauma.
• Integrated Traditional Chinese and Western Medicine Treatment: Acupuncture, moxibustion, herbal medicine, and tuina to improve pelvic floor muscle function, relieve chronic pelvic pain, and enhance the effect of pelvic floor rehabilitation, a featured treatment in China.
• Perioperative Management & Postoperative Rehabilitation: Personalized preoperative evaluation and postoperative rehabilitation training to improve surgical efficacy and reduce recurrence risk.